Methylation of miR-34a, miR-34b/c, miR-124-1 and miR-203 in Ph-negative myeloproliferative neoplasms
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1479-5876
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Methylation of miR-34a, miR-34b/c, miR-124-1 and miR-203 in Ph-negative myeloproliferative neoplasms ; volume:9 ; number:1 ; day:14 ; month:11 ; year:2011 ; pages:1-10 ; date:12.2011
Journal of translational medicine ; 9, Heft 1 (14.11.2011), 1-10, 12.2011
- Creator
-
Chim, Chor Sang
- Contributor
-
Wan, Thomas S.
Wong, Kwan Yeung
Fung, Tsz Kin
Drexler, Hans G.
Wong, Kit Fai
SpringerLink (Online service)
- DOI
-
10.1186/1479-5876-9-197
- URN
-
urn:nbn:de:1111-2016041437593
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:45 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Chim, Chor Sang
- Wan, Thomas S.
- Wong, Kwan Yeung
- Fung, Tsz Kin
- Drexler, Hans G.
- Wong, Kit Fai
- SpringerLink (Online service)
Other Objects (12)
Clinical relevance of microRNA miR-21, miR-31, miR-92a, miR-101, miR-106a and miR-145 in colorectal cancer
MiR
miR
MiR-10a and HOXB4 are overexpressed in atypical myeloproliferative neoplasms
Interactions of miR-323/miR-326/miR-329 and miR-130a/miR-155/miR-210 as prognostic indicators for clinical outcome of glioblastoma patients
MicroRNAs miR-19, miR-340, miR-374 and miR-542 regulate MID1 protein expression
Microvesicle-associated and circulating microRNAs in diabetic dyslipidemia: miR-218, miR-132, miR-143, and miR-21, miR-122, miR-155 have biomarker potential
Zu MiR
Serum levels of miR-29, miR-122, miR-155 and miR-192 are elevated in patients with cholangiocarcinoma
Identification of miR-10b, miR-26a, miR-146a and miR-153 as potential triple-negative breast cancer biomarkers
Expression of miR-1, miR-133a, miR-133b and miR-206 increases during development of human skeletal muscle
MiR-34a and miR-34b/c have distinct effects on the suppression of lung adenocarcinomas
Clinical relevance of microRNA miR-21, miR-31, miR-92a, miR-101, miR-106a and miR-145 in colorectal cancer
MiR
miR
MiR-10a and HOXB4 are overexpressed in atypical myeloproliferative neoplasms
Interactions of miR-323/miR-326/miR-329 and miR-130a/miR-155/miR-210 as prognostic indicators for clinical outcome of glioblastoma patients
MicroRNAs miR-19, miR-340, miR-374 and miR-542 regulate MID1 protein expression
Microvesicle-associated and circulating microRNAs in diabetic dyslipidemia: miR-218, miR-132, miR-143, and miR-21, miR-122, miR-155 have biomarker potential
Zu MiR
Serum levels of miR-29, miR-122, miR-155 and miR-192 are elevated in patients with cholangiocarcinoma
Identification of miR-10b, miR-26a, miR-146a and miR-153 as potential triple-negative breast cancer biomarkers
Expression of miR-1, miR-133a, miR-133b and miR-206 increases during development of human skeletal muscle
MiR-34a and miR-34b/c have distinct effects on the suppression of lung adenocarcinomas
Clinical relevance of microRNA miR-21, miR-31, miR-92a, miR-101, miR-106a and miR-145 in colorectal cancer
MiR
miR
MiR-10a and HOXB4 are overexpressed in atypical myeloproliferative neoplasms
Interactions of miR-323/miR-326/miR-329 and miR-130a/miR-155/miR-210 as prognostic indicators for clinical outcome of glioblastoma patients
MicroRNAs miR-19, miR-340, miR-374 and miR-542 regulate MID1 protein expression
Microvesicle-associated and circulating microRNAs in diabetic dyslipidemia: miR-218, miR-132, miR-143, and miR-21, miR-122, miR-155 have biomarker potential
Zu MiR
Serum levels of miR-29, miR-122, miR-155 and miR-192 are elevated in patients with cholangiocarcinoma
Identification of miR-10b, miR-26a, miR-146a and miR-153 as potential triple-negative breast cancer biomarkers
Expression of miR-1, miR-133a, miR-133b and miR-206 increases during development of human skeletal muscle